Neuropathic pain is the most common, chronic state of pain usually associated with tissue injury. It can lead to injury, dysfunction, or damage to the nerve fibers, resulting in signal misappropriation to other pain centers. The effect of nerve fiber damage involves a shift in the function of the nerve instead at the injury site and the injury area.
The global demand for the neuropathic pain market is projected to be worth US$ 6.313.4 million in 2019 and is anticipated to hit US$ 9.862.3 million by the end of 2027.
Global demand for Neuropathic Pain Market: prospects
The production of therapeutic agents targeting peripherally constrained cannabinoid receptors (CBs) is expected to provide substantial growth potential for market players. Researchers at Matsumoto Dental University, Japan, for example, concluded in February 2020 that CB2 receptors, peripherally restricted CB1 receptors, and endocannabinoid degrading enzymes are a potentially successful technique to alleviate neuropathic pain symptoms with minimal side effects.
To know the latest trends and insights prevalent in this market, click the link below: https://www.globenewswire.com/news-release/2020/05/25/2038154/0/en/Neuropathic-Pain-Market-to-reach-US-9-862-3-Million-globally-by-2027-Coherent-Market-Insights.html